TIF1γ requires sumoylation to exert its repressive activity on TGFβ signaling

Journal of Cell Science

Volumn 126, Issue 16, 2013, Pages 3713-3723

  Fattet, Laurent ^a,b   Ay, Anne Sophie ^a,b,d   Bonneau, Benjamin ^a,b   Jallades, Laurent ^a,b,e   Mikaelian, Ivan ^a,b   Treilleux, Isabelle ^c   Gillet, Germain ^a,b   Hesling, Cédric ^a,c   Rimokh, Ruth ^a,b,c  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c CENTRE LÉON BÉRARD   (France)

^d Université Picardie Jules Vernes   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Smad; Sumoylation; TGFbeta; TIF1gamma; TRIM33

Indexed keywords

PROTEIN UBC9; SMAD4 PROTEIN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL INTERMEDIARY FACTOR 1 GAMMA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BREAST EPITHELIUM; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; EPITHELIAL MESENCHYMAL TRANSITION; LACTATION; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SUMOYLATION;

SMAD; SUMOYLATION; TGFBETA; TIF1GAMMA; TRIM33;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; HUMANS; MOLECULAR SEQUENCE DATA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; SMAD PROTEINS; SUMOYLATION; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84883403790     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.126748     Document Type: Article

References (43)

1. Agricola, E., Randall, R. A., Gaarenstroom, T., Dupont, S. and Hill, C. S. (2011). Recruitment of TIF1c to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol. Cell 43, 85-96.
2. Albers, M., Kranz, H., Kober, I., Kaiser, C., Klink, M., Suckow, J., Kern, R. and Koegl, M. (2005). Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. Mol. Cell. Proteomics 4, 205-213.
3. Andrieux, G., Fattet, L., Le Borgne, M., Rimokh, R. and Théret, N. (2012). Dynamic regulation of Tgf-B signaling by Tif1c: a computational approach. PLoS ONE 7, e33761.
4. Aucagne, R., Droin, N., Paggetti, J., Lagrange, B., Largeot, A., Hammann, A., Bataille, A., Martin, L., Yan, K.-P., Fenaux, P. et al. (2011). Transcription intermediary factor 1c is a tumor suppressor in mouse and human chronic myelomonocytic leukemia. J. Clin. Invest. 121, 2361-2370.
5. Bai, X., Kim, J., Yang, Z., Jurynec, M. J., Akie, T. E., Lee, J., LeBlanc, J., Sessa, A., Jiang, H., DiBiase, A. et al. (2010). TIF1c controls erythroid cell fate by regulating transcription elongation. Cell 142, 133-143.
6. Cheng, J., Kang, X., Zhang, S. and Yeh, E. T. H. (2007). SUMO-specific protease 1 is essential for stabilization of HIF1a during hypoxia. Cell 131, 584-595.
7. Deheuninck, J. and Luo, K. (2009). Ski and SnoN, potent negative regulators of TGF-β signaling. Cell Res. 19, 47-57.
8. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S. and Gauthier, J. M. (1998). Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100.
9. Dupont, S., Zacchigna, L., Cordenonsi, M., Soligo, S., Adorno, M., Rugge, M. and Piccolo, S. (2005). Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121, 87-99.
10. Dupont, S., Mamidi, A., Cordenonsi, M., Montagner, M., Zacchigna, L., Adorno, M., Martello, G., Stinchfield, M. J., Soligo, S., Morsut, L. et al. (2009). FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136, 123-135.
11. Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C. and Weinberg, R. A. (2001). Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50-65.
12. Gareau, J. R. and Lima, C. D. (2010). The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11, 861-871.
13. He, W., Dorn, D. C., Erdjument-Bromage, H., Tempst, P., Moore, M. A. S. and Massagué, J. (2006). Hematopoiesis controlled by distinct TIF1c and Smad4 branches of the TGFbeta pathway. Cell 125, 929-941.
14. Herquel, B., Ouararhni, K., Khetchoumian, K., Ignat, M., Teletin, M., Mark, M., Béchade, G., Van Dorsselaer, A., Sanglier-Cianférani, S., Hamiche, A. et al. (2011). Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 108, 8212-8217.
15. Hesling, C., Fattet, L., Teyre, G., Jury, D., Gonzalo, P., Lopez, J., Vanbelle, C., Morel, A.-P., Gillet, G., Mikaelian, I. et al. (2011). Antagonistic regulation of EMT by TIF1c and Smad4 in mammary epithelial cells. EMBO Rep. 12, 665-672.
16. Hesling, C., Lopez, J., Fattet, L., Gonzalo, P., Treilleux, I., Blanchard, D., Losson, R., Goffin, V., Pigat, N., Puisieux, A. et al. (2013). Tif1c is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibition. Development 140, 167-175.
17. Imoto, S., Ohbayashi, N., Ikeda, O., Kamitani, S., Muromoto, R., Sekine, Y. and Matsuda, T. (2008). Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-b signaling. Biochem. Biophys. Res. Commun. 370, 359-365.
18. Ivanov, A. V., Peng, H., Yurchenko, V., Yap, K. L., Negorev, D. G., Schultz, D. C., Psulkowski, E., Fredericks, W. J., White, D. E., Maul, G. G. et al. (2007). PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol. Cell 28, 823-837.
19. Jakobs, A., Koehnke, J., Himstedt, F., Funk, M., Korn, B., Gaestel, M. and Niedenthal, R. (2007). Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Nat. Methods 4, 245-250.
20. Kang, J. S., Saunier, E. F., Akhurst, R. J. and Derynck, R. (2008). The type I TGF-b receptor is covalently modified and regulated by sumoylation. Nat. Cell Biol. 10, 654-664.
21. Kusy, S., Gault, N., Ferri, F., Lewandowski, D., Barroca, V., Jaracz-Ros, A., Losson, R. and Romeo, P.-H. (2011). Adult hematopoiesis is regulated by TIF1c, a repressor of TAL1 and PU.1 transcriptional activity. Cell Stem Cell 8, 412-425.
22. Lamesch, P., Li, N., Milstein, S., Fan, C., Hao, T., Szabo, G., Hu, Z., Venkatesan, K., Bethel, G., Martin, P. et al. (2007). hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics 89, 307-315.
23. Lee, P. S. W., Chang, C., Liu, D. and Derynck, R. (2003). Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling. J. Biol. Chem. 278, 27853-27863.
24. Levy, L., Howell, M., Das, D., Harkin, S., Episkopou, V. and Hill, C. S. (2007). Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol. Cell. Biol. 27, 6068-6083.
25. Lin, X., Liang, M., Liang, Y.-Y., Brunicardi, F. C. and Feng, X.-H. (2003). SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J. Biol. Chem. 278, 31043-31048.
26. Long, J., Wang, G., He, D. and Liu, F. (2004). Repression of Smad4 transcriptional activity by SUMO modification. Biochem. J. 379, 23-29.
27. Lönn, P., Morén, A., Raja, E., Dahl, M. and Moustakas, A. (2009). Regulating the stability of TGFbeta receptors and Smads. Cell Res. 19, 21-35.
28. Mascle, X. H., Germain-Desprez, D., Huynh, P., Estephan, P. and Aubry, M. (2007). Sumoylation of the transcriptional intermediary factor 1beta (TIF1beta), the co-repressor of the KRAB Multifinger proteins, is required for its transcriptional activity and is modulated by the KRAB domain. J. Biol. Chem. 282, 10190-10202.
29. Massagué, J., Seoane, J. and Wotton, D. (2005). Smad transcription factors. Genes Dev. 19, 2783-2810.
30. Miles, W. O., Jaffray, E., Campbell, S. G., Takeda, S., Bayston, L. J., Basu, S. P., Li, M., Raftery, L. A., Ashe, M. P., Hay, R. T. et al. (2008). Medea SUMOylation restricts the signaling range of the Dpp morphogen in the Drosophila embryo. Genes Dev. 22, 2578-2590.
31. Morsut, L., Yan, K. P., Enzo, E., Aragona, M., Soligo, S. M., Wendling, O., Mark, M., Khetchoumian, K., Bressan, G., Chambon, P. et al. (2010). Negative control of Smad activity by ectodermin/Tif1c patterns the mammalian embryo. Development 137, 2571-2578.
32. Moustakas, A. and Heldin, C. H. (2009). The regulation of TGFbeta signal transduction. Development 136, 3699-3714.
33. Ohshima, T. and Shimotohno, K. (2003). Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4. J. Biol. Chem. 278, 50833-50842.
34. Ransom, D. G., Bahary, N., Niss, K., Traver, D., Burns, C., Trede, N. S., Paffett-Lugassy, N., Saganic, W. J., Lim, C. A., Hersey, C. et al. (2004). The zebrafish moonshine gene encodes transcriptional intermediary factor 1c, an essential regulator of hematopoiesis. PLoS Biol. 2, e237.
35. Seeler, J. S., Marchio, A., Losson, R., Desterro, J. M., Hay, R. T., Chambon, P. and Dejean, A. (2001). Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification. Mol. Cell. Biol. 21, 3314-3324.
36. Tatham, M. H., Geoffroy, M. C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J. and Hay, R. T. (2008). RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10, 538-546.
37. Tirard, M., Hsiao, H.-H., Nikolov, M., Urlaub, H., Melchior, F. and Brose, N. (2012). In vivo localization and identification of SUMOylated proteins in the brain of His6-HA-SUMO1 knock-in mice. Proc. Natl. Acad. Sci. USA 109, 21122-21127.
38. Venturini, L., You, J., Stadler, M., Galien, R., Lallemand, V., Koken, M. H., Mattei, M. G., Ganser, A., Chambon, P., Losson, R. et al. (1999). TIF1gamma, a novel member of the transcriptional intermediary factor 1 family. Oncogene 18, 1209-1217.
39. Vincent, D. F., Yan, K.-P., Treilleux, I., Gay, F., Arfi, V., Kaniewski, B., Marie, J. C., Lepinasse, F., Martel, S., Goddard-Leon, S. et al. (2009). Inactivation of TIF1c cooperates with Kras to induce cystic tumors of the pancreas. PLoS Genet. 5, e1000575.
40. Xi, Q., Wang, Z., Zaromytidou, A.-I., Zhang, X. H. F., Chow-Tsang, L.-F., Liu, J. X., Kim, H., Barlas, A., Manova-Todorova, K., Kaartinen, V. et al. (2011). A poised chromatin platform for TGF-b access to master regulators. Cell 147, 1511-1524.
41. Xu, P., Liu, J. and Derynck, R. (2012). Post-translational regulation of TGF-b receptor and Smad signaling. FEBS Lett. 586, 1871-1884.
42. Yan, K.-P., Dollé, P., Mark, M., Lerouge, T., Wendling, O., Chambon, P. and Losson, R. (2004). Molecular cloning, genomic structure, and expression analysis of the mouse transcriptional intermediary factor 1 gamma gene. Gene 334, 3-13.
43. Yeh, E. T. H. (2009). SUMOylation and De-SUMOylation: wrestling with life's processes. J. Biol. Chem. 284, 8223-8227.